(Q44749301)

5 December 2017

title

Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease (English)

1 reference

5 December 2017

5

David E J Jones

1 reference

5 December 2017

Stephen F Stewart

1

1 reference

5 December 2017

Matteo Vidali

series ordinal

2

1 reference

5 December 2017

Christopher P Day

series ordinal

3

1 reference

5 December 2017

Emanuele Albano

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

39

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

197-203

1 reference

Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group

5 December 2017

cites work

1 reference

7 January 2021

Alcoholic liver disease: new insights into mechanisms and preventative strategies

1 reference

7 January 2021

Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1)

1 reference

7 January 2021

Spin trapping of free radical species produced during the microsomal metabolism of ethanol

1 reference

7 January 2021

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

1 reference

7 January 2021

Inactivation of Kupffer cells prevents early alcohol-induced liver injury

1 reference

7 January 2021

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

7 January 2021

Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease

1 reference

7 January 2021

Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis.

1 reference

7 January 2021

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

1 reference

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

7 January 2021

Zonal distribution of protein-acetaldehyde adducts in the liver of rats fed alcohol for long periods

1 reference

7 January 2021

Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption

1 reference

7 January 2021

Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts

1 reference

7 January 2021

Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease

1 reference

7 January 2021

Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol

1 reference

7 January 2021

Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275.

1 reference

7 January 2021

Selective inhibition of antigen-specific T lymphocyte proliferation by acute ethanol exposure: the role of impaired monocyte antigen presentation capacity and mediator production

1 reference

7 January 2021

Role of lipid peroxidation and oxidative stress in alcohol toxicity

1 reference

7 January 2021

Implication of free radical mechanisms in ethanol-induced cellular injury

1 reference

7 January 2021

Role of malondialdehyde-acetaldehyde adducts in liver injury

1 reference

7 January 2021

Free radical mechanisms in immune reactions associated with alcoholic liver disease.

1 reference

7 January 2021

Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease

1 reference

7 January 2021

Portal lymphocytic infiltrate in alcoholic liver disease

1 reference

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

7 January 2021

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20021

1 reference

5 December 2017

1 reference